تجاوز إلى المحتوى الرئيسي
من
المنتج التاريخ معلومات السلامة المرفقات
Zelboraf® - Vemurafenib 2014-03-02

Risk of liver injury reported with  Zelboraf®. ​

Neupogen® - Filgrastim 2014-01-26

Risk of capillary leak syndrome in patients with cancer.  ​

ZOFRAN® - Ondansetron 2013-08-29

Updated information on posology for intravenous use and dose dependant QT interval prolongation.  

Diane-35® - Ethinylestradiol/Cyproterne 2013-07-22

Risk of Thromboembolism.  

LARIAM® - Mefloquine 2013-07-16

Important Safety Update of Prescribing Information for LARIAM®. 

 

MabThera® - Rituximab 2013-07-16

The management of hepatitis B reactivation in patients treated with MabThera®.  CLICK HERE​

Fenatnyl‐Janssen ® - Fentanyl 2013-07-14

Fenatnyl‐Janssen Introduction of New Warning ‐ Serontonin syndrome may occur under co‐administration with serotonergic drugs.  

 

DUROGESIC® -Fentanyl 2013-07-14

Introduction of New Warning-Serontonin syndrome may occur under co-administration with serotonergic drugs.  

 

TASIGNA® - Nilotinib 2013-07-14

Updated information regarding the possible risk of developing atherosclerosis-related diseases with the use of TASIGNA®.  ​

VOTRIENT® - Pazopanib 2013-07-14

Important change to frequency of Serum liver test monitoring for hepatotoxicity.  

 

عرض 71 - 80 من 105